Showing results (621-630 of 1,751) with videos related to

Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 1, 1997
Enhancement of lymphokine-activated killer cell activity by fibronectinY Q Li, M Kobayashi, Y Kuramitsu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 23, 2016
Clinical Response Rates From Interleukin-2 Therapy for Metastatic Melanoma Over 30 Years' Experience: A Meta-Analysis of 3312 PatientsRichard Bright, Brendon J Coventry, Nathan Eardley-Harris, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 10, 2014
High-dose interleukin 2-induced myocarditis: can myocardial damage reversibility be assessed by cardiac MRI?Shien Chow, Laura Cove-Smith, Matthias Schmitt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2016
Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40Noam Levin, Aviad Pato, Gal Cafri, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2017
A Preliminary Report: Radical Surgery and Stem Cell Transplantation for the Treatment of Patients With Pancreatic CancerBrigitta Omazic, Burcu Ayoglu, Matthias Löhr, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 25, 2017
NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLCTomohira Takeoka, Hirotsugu Nagase, Koji Kurose, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 10, 2014
Universal artificial antigen presenting cells to selectively propagate T cells expressing chimeric antigen receptor independent of specificityDavid Rushworth, Bipulendu Jena, Simon Olivares, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 8, 2017
Nivolumab Causing a Polymyalgia Rheumatica in a Patient With a Squamous Non-Small Cell Lung CancerMarjorie Bernier, Cyril Guillaume, Nathalie Leon, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2017
Possible Compartmental Cytokine Release Syndrome in a Patient With Recurrent Ovarian Cancer After Treatment With Mesothelin-targeted CAR-T CellsJanos L Tanyi, Caitlin Stashwick, Gabriela Plesa, et al.
Pageof 176